As cell and gene therapies scale globally, maintaining the integrity of cryopreserved biomaterials during transit is critical. Yet package failure, leakage events and temperature excursions persist, leaving patients at risk and contributing to the estimated $35 billion in industry losses from cold-chain disruptions. This webinar will examine proven strategies to significantly reduce blood bag breakage and leakage during cryogenic transport, safeguarding patient safety, ensuring regulatory compliance and minimizing costly product loss.
In this webinar, the featured speakers will highlight findings from a comprehensive validation study of an integrated cryogenic shipping system designed to address these challenges. Attendees will learn how an absorbent soft-rack containment system, paired with advanced cryogenic shipping systems eliminate common points of failure, including contact damage caused by inadvertent vibration or drops. This webinar will also discuss details of controlled distribution tests conducted in accordance with IATA and ASTM standards, comparing traditional shippers with metal racks to more innovative solutions. The speakers will further discuss the outcomes from real-world shipping studies involving multi-leg international shipping lanes to validate performance in everyday handling and shipping procedures. Finally, findings confirming payload absorbency and containment in the event of catastrophic damage will be presented.
Together, these results will demonstrate the critical role of purpose-engineered shipping innovations in enabling the scalable distribution of tomorrow’s advanced therapies.
Register for this webinar to learn how Cryoport Systems supports strategies for reducing blood bag breakage and leakage risk in cryogenic transport.
Speakers
Alexandre Michaux, PhD, Process Development & MSAT Manager, Cryoport Systems
Alexandre is an expert in cell therapy process development and cryoprocessing, with over 15 years of experience in the cell and gene therapy field. After completing his PhD thesis at the Ludwig Institute for Cancer Research in Brussels, he began his career specializing in CAR-T development within biotech before joining Cryoport Systems, where he currently serves as Process Development and MSAT Manager. In this role, Alexandre supports cryopreservation strategy, manages cross-regional teams and supports global supply chain optimization for advanced therapies.
Message Presenter
Khoa Tran, Senior Director, NPD Product Marketing, Cryoport Systems
Khoa Tran joined Cryoport Systems in 2021 and leads Product Management and Product Marketing within Product Development. He partners closely with cell and gene therapy manufacturers to capture voice-of-customer insights and translate market needs into product improvements and new solutions. His work has supported the launch of innovative offerings, including the Cryoport Elite® Ultra Cold Shipping System and the Safepak® Soft System 1800.
Message Presenter
Edward Grimley, PhD, Manager, Global Lead Generation, Cryoport Systems
Ed holds a PhD from the University of Michigan in Cellular and Molecular Pathology and has spent the better part of the last 19 years in various roles supporting drug discovery and development, including the cell and gene therapy industry over the past six years. Ed has been with Cryoport Systems for nearly two years, where he has been passionately supporting innovative advanced therapy supply chain initiatives designed to enable better outcomes for our partners and their patients.
Message Presenter
Who Should Attend?
This webinar will appeal to professionals with roles in:
- Supply chain, logistics or operations
- Quality assurance, compliance or regulatory affairs
- MSAT, CMC, PD or R&D
- Preclinical discovery
- Clinical trial management
- Clinical to commercial scale-up
- Consulting or contract research or manufacturing
- Vendor supply chain management
What You Will Learn
Attendees will gain insight into:
- The true cost of cold-chain failures and why blood bag breakage remains a risk in advanced therapy logistics
- Aligning investor expectations and streamlining operations through practical operational efficiencies for an evolving regulatory environment
- Benchmarking and performance qualification data highlighting superior payload protection when pairing non-traditional transport systems
- How purpose-built shipping innovations meet IATA and ASTM regulatory standards to ensure compliance, reduce risks and safeguard valuable materials
Xtalks Partner
Cryoport Systems
Cryoport Systems is a market leader in globally integrated temperature-controlled supply chain support for critical, irreplaceable products and materials in the Life Sciences industry. We are already trusted to support over 650 active clinical trials and leading commercial products worldwide, delivering unparalleled, integrated supply chain services for products, therapies and treatments requiring unique, specialized temperature-controlled management. And, as the Life Sciences constantly evolve and advance, so do we.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account